Actively Recruiting
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-02-27
20
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been recently restored to normal weight and adult women with no history of eating disorders. After enrollment, participants will start meeting weekly with a registered dietitian to implement the Metabolic Diet in their daily lives, and will receive medical monitoring for adherence, side effects, changes in metabolic or psychological parameters, and weight stability.
CONDITIONS
Official Title
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Age between 18 and 40 years
- Body mass index (BMI) at or above 18.5 kg/m2
- Speaks English
- Medically stable as confirmed by a licensed physician with vital signs and blood tests
- History of anorexia nervosa diagnosis (for weight-restored anorexia nervosa group only)
- Restored to normal weight from underweight BMI within the past 6 months (for weight-restored anorexia nervosa group only)
You will not qualify if you...
- Current or lifetime diagnosis of psychotic or bipolar disorders
- Active substance use disorders
- Taking medications that could affect metabolism (must be free from these for 2 weeks before glucose testing)
- History of suicide attempt in the past 6 months or acute suicide risk
- Significant current medical illness or metabolic conditions, including diabetes and pregnancy
- Current or lifetime diagnosis of eating disorders (healthy control group only)
- Active depressive disorders (healthy control group only)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
C
Chinara Tate
CONTACT
T
Tom Hildebrandt
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here